BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19403523)

  • 41. Ligand binding and activation in a prokaryotic cyclic nucleotide-modulated channel.
    Nimigean CM; Pagel MD
    J Mol Biol; 2007 Aug; 371(5):1325-37. PubMed ID: 17619023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutating protein kinase cAMP-binding sites into cGMP-binding sites. Mechanism of cGMP selectivity.
    Shabb JB; Buzzeo BD; Ng L; Corbin JD
    J Biol Chem; 1991 Dec; 266(36):24320-6. PubMed ID: 1662209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells.
    Kang G; Chepurny OG; Malester B; Rindler MJ; Rehmann H; Bos JL; Schwede F; Coetzee WA; Holz GG
    J Physiol; 2006 Jun; 573(Pt 3):595-609. PubMed ID: 16613879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis.
    Hochbaum D; Hong K; Barila G; Ribeiro-Neto F; Altschuler DL
    J Biol Chem; 2008 Feb; 283(8):4464-8. PubMed ID: 18063584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural dynamics in the activation of Epac.
    Harper SM; Wienk H; Wechselberger RW; Bos JL; Boelens R; Rehmann H
    J Biol Chem; 2008 Mar; 283(10):6501-8. PubMed ID: 18167352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes.
    Pereira L; Rehmann H; Lao DH; Erickson JR; Bossuyt J; Chen J; Bers DM
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3991-6. PubMed ID: 25829540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.
    Birukova AA; Zagranichnaya T; Alekseeva E; Bokoch GM; Birukov KG
    J Cell Physiol; 2008 Jun; 215(3):715-24. PubMed ID: 18064650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of State-Specific Association Constants in Allosteric Sensors through Molecular Stapling and NMR.
    Moleschi KJ; Akimoto M; Melacini G
    J Am Chem Soc; 2015 Aug; 137(33):10777-85. PubMed ID: 26247242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fractionation factors reveal hidden frustration in an ancient allosteric module.
    VanSchouwen B; Della Libera L; Melacini G
    J Chem Phys; 2023 Mar; 158(12):121101. PubMed ID: 37003757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Communication between tandem cAMP binding domains in the regulatory subunit of protein kinase A-Ialpha as revealed by domain-silencing mutations.
    McNicholl ET; Das R; SilDas S; Taylor SS; Melacini G
    J Biol Chem; 2010 May; 285(20):15523-15537. PubMed ID: 20202931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural basis for cyclic-nucleotide selectivity and cGMP-selective activation of PKG I.
    Huang GY; Kim JJ; Reger AS; Lorenz R; Moon EW; Zhao C; Casteel DE; Bertinetti D; Vanschouwen B; Selvaratnam R; Pflugrath JW; Sankaran B; Melacini G; Herberg FW; Kim C
    Structure; 2014 Jan; 22(1):116-24. PubMed ID: 24239458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
    Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
    Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation.
    Huston E; Lynch MJ; Mohamed A; Collins DM; Hill EV; MacLeod R; Krause E; Baillie GS; Houslay MD
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12791-6. PubMed ID: 18728186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP.
    de Rooij J; Zwartkruis FJ; Verheijen MH; Cool RH; Nijman SM; Wittinghofer A; Bos JL
    Nature; 1998 Dec; 396(6710):474-7. PubMed ID: 9853756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of cyclic AMP in Jurkat T-cells provokes distinct transcriptional responses through the protein kinase A (PKA) and exchange protein activated by cyclic AMP (EPAC) pathways.
    Fuld S; Borland G; Yarwood SJ
    Exp Cell Res; 2005 Sep; 309(1):161-73. PubMed ID: 15963501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrostatic Interactions as Mediators in the Allosteric Activation of Protein Kinase A RIα.
    P Barros E; Malmstrom RD; Nourbakhsh K; Del Rio JC; Kornev AP; Taylor SS; Amaro RE
    Biochemistry; 2017 Mar; 56(10):1536-1545. PubMed ID: 28221775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion.
    Raymond DR; Wilson LS; Carter RL; Maurice DH
    Cell Signal; 2007 Dec; 19(12):2507-18. PubMed ID: 17884339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trypanosome cyclic nucleotide phosphodiesterase 2B binds cAMP through its GAF-A domain.
    Laxman S; Rascón A; Beavo JA
    J Biol Chem; 2005 Feb; 280(5):3771-9. PubMed ID: 15563461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP.
    Birukova AA; Burdette D; Moldobaeva N; Xing J; Fu P; Birukov KG
    Microvasc Res; 2010 Mar; 79(2):128-38. PubMed ID: 19962392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes.
    Petersen RK; Madsen L; Pedersen LM; Hallenborg P; Hagland H; Viste K; Døskeland SO; Kristiansen K
    Mol Cell Biol; 2008 Jun; 28(11):3804-16. PubMed ID: 18391018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.